AURKA and hepatocellular carcinoma: AURKA showed a marked increase in Hepatitis B virus+ (HBV+) HCC samples compared to the paired HBV+ non‐tumoural liver tissues in GSE14520 [128.00 (78.79–219.79) vs. 26.35 (22.63–33.63)] and GSE121248 datasets [227.54 (155.42–335.46) vs. 80.45 (64.00–101.83)].68